6/08/2009

Biotechnology

I have no expertise with biotechnology but did write the following about using insider activity with biotechnology stocks.

It seems logical Insider activity within certain industries such as biotechnology may provide more directional information. The thesis is management understands the science and future possibilities of new drug breakthroughs or ability to pass future FDA hurdles

Link

http://seekingalpha.com/article/130846-how-to-interpret-insider-transactions

DYAX was provided on my value insider list on Sunday.

Link

http://www.shadowstock.com/ss_060509.html

Insider Activity for DYAX

http://finance.yahoo.com/q/it?s=DYAX

The idea may be worth a closer look.

No comments: